BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35704284)

  • 1. Clonidine ameliorates cisplatin-induced nephrotoxicity: impact on OCT2 and p38 MAPK pathway.
    Fawzy MH; Khodeer DM; Elsayed NM; Ahmed YM; Saeed NM
    J Pharm Pharmacol; 2022 Aug; 74(8):1180-1192. PubMed ID: 35704284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats.
    Alhoshani AR; Hafez MM; Husain S; Al-Sheikh AM; Alotaibi MR; Al Rejaie SS; Alshammari MA; Almutairi MM; Al-Shabanah OA
    BMC Nephrol; 2017 Jun; 18(1):194. PubMed ID: 28619064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage.
    Francescato HD; Costa RS; Silva CG; Coimbra TM
    Life Sci; 2009 Apr; 84(17-18):590-7. PubMed ID: 26324989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented nephroprotective effect of liraglutide and rabeprazole via inhibition of OCT2 transporter in cisplatin-induced nephrotoxicity in rats.
    Sharaf G; E M EM; El-Sayed EK
    Life Sci; 2023 May; 321():121609. PubMed ID: 36958435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage.
    Francescato HD; Costa RS; da Silva CG; Coimbra TM
    Life Sci; 2009 Apr; 84(17-18):590-7. PubMed ID: 19302802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin inhibits NADPH oxidase and P38 MAPK in cisplatin-induced nephrotoxicity.
    Rashed LA; Hashem RM; Soliman HM
    Biomed Pharmacother; 2011 Oct; 65(7):474-80. PubMed ID: 21993003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galangin ameliorates cisplatin induced nephrotoxicity in vivo by modulation of oxidative stress, apoptosis and inflammation through interplay of MAPK signaling cascade.
    Tomar A; Vasisth S; Khan SI; Malik S; Nag TC; Arya DS; Bhatia J
    Phytomedicine; 2017 Oct; 34():154-161. PubMed ID: 28899498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wedelolactone protects against cisplatin-induced nephrotoxicity in mice via inhibition of organic cation transporter 2.
    Wang G; Bi Y; Xiong H; Bo T; Han L; Zhou L; Zhang C; Zhang Y
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S447-S459. PubMed ID: 34592875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity.
    Filipski KK; Mathijssen RH; Mikkelsen TS; Schinkel AH; Sparreboom A
    Clin Pharmacol Ther; 2009 Oct; 86(4):396-402. PubMed ID: 19625999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole protects against cisplatin-induced nephrotoxicity by alleviating oxidative stress, inflammation, and transporter-mediated cisplatin accumulation in rats and HK-2 cells.
    Gao H; Zhang S; Hu T; Qu X; Zhai J; Zhang Y; Tao L; Yin J; Song Y
    Chem Biol Interact; 2019 Jan; 297():130-140. PubMed ID: 30452898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoquinone and geraniol alleviate cisplatin-induced neurotoxicity in rats through downregulating the p38 MAPK/STAT-1 pathway and oxidative stress.
    Kandeil MA; Mahmoud MO; Abdel-Razik AH; Gomaa SB
    Life Sci; 2019 Jul; 228():145-151. PubMed ID: 31047895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity.
    Yokoo S; Yonezawa A; Masuda S; Fukatsu A; Katsura T; Inui K
    Biochem Pharmacol; 2007 Aug; 74(3):477-87. PubMed ID: 17582384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats.
    Luo J; Tsuji T; Yasuda H; Sun Y; Fujigaki Y; Hishida A
    Nephrol Dial Transplant; 2008 Jul; 23(7):2198-205. PubMed ID: 18385389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment of epigallocatechin gallate and Coenzyme Q10 attenuates cisplatin-induced nephrotoxicity via suppression of oxidative/nitrosative stress, inflammation and cellular damage.
    Fatima S; Al-Mohaimeed N; Al-Shaikh Y; Tyagi P; Banu N; Hasan S; Arjumand S
    Food Chem Toxicol; 2016 Aug; 94():213-20. PubMed ID: 27265264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Effect of Penetratin Analogue-Tagged SOD1 on Cisplatin-Induced Nephrotoxicity through Inhibiting Oxidative Stress and JNK/p38 MAPK Signaling Pathway.
    Wang XL; Wang L; Lin FL; Li SS; Lin TX; Jiang RW
    Oxid Med Cell Longev; 2021; 2021():5526053. PubMed ID: 34471466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan ameliorates cisplatin-induced nephrotoxicity by inhibiting MAPK mediated inflammation and apoptosis.
    Malik S; Suchal K; Gamad N; Dinda AK; Arya DS; Bhatia J
    Eur J Pharmacol; 2015 Feb; 748():54-60. PubMed ID: 25510231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective mechanisms of chlorogenic acid in cisplatin-induced kidney injury.
    Domitrović R; Cvijanović O; Šušnić V; Katalinić N
    Toxicology; 2014 Oct; 324():98-107. PubMed ID: 25043994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase.
    Franke RM; Kosloske AM; Lancaster CS; Filipski KK; Hu C; Zolk O; Mathijssen RH; Sparreboom A
    Clin Cancer Res; 2010 Aug; 16(16):4198-206. PubMed ID: 20601443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteolin ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of platinum accumulation, inflammation and apoptosis in the kidney.
    Domitrović R; Cvijanović O; Pugel EP; Zagorac GB; Mahmutefendić H; Škoda M
    Toxicology; 2013 Aug; 310():115-23. PubMed ID: 23770416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).
    Li Q; Guo D; Dong Z; Zhang W; Zhang L; Huang SM; Polli JE; Shu Y
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):100-9. PubMed ID: 24001450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.